Company Search:
Advanced Search
Sponsored Links
Entest Biomedical Inc Company Snapshot
Entest Biomedical Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Entest Biomedical Inc with three other companies in this sector in the United States: Diffusion Pharmaceuticals Inc (2012 sales of $374,542.00 ), Tenax Therapeutics Inc ($415,034.00 of which 100% was Biotechnology Product), and bluebird bio Inc ($340,000.00 of which 100% was Biological Products).

Sales Analysis.
  Stock Performance Chart for Entest Biomedical Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): .04
(Figures in U.S. Dollars)
1 Week -5.0%   13 Weeks 26.7%  
4 Weeks 11.8%   52 Weeks -5.0%  
Entest Biomedical Inc Key Data:
  Ticker: ENTB Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2012 Sales 426,252
(Year Ending Jan 2013).
Employees: 10
  Currency: U.S. Dollars Market Cap: 1,868,478
  Fiscal Yr Ends: August Shares Outstanding: 49,170,472
  Share Type: Common Closely Held Shares: 25,800,001
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.